Ozempic profits are helping fund a new Nvidia-powered AI supercomputer
By Olesya Dmitracova, CNN London (CNN) — The owner of Novo Nordisk, the drugmaker that gave the world Ozempic and Wegovy, is funding a new supercomputer powered by Nvidia’s artificial intelligence technology with a key aim of discovering new medicines and treatments. The Novo Nordisk Foundation has awarded France’s Eviden a contract to build what
Continue Reading